Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Tournilhac

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
La Revue Du Praticien|May 25, 1999
[Superficial adenopathy]O Tournilhac, P Travade
Bulletin Du Cancer|June 17, 2000
[Importance of thalidomide in the treatment of cancer]J O Bay, O Tournilhac
Presse Medicale (Paris, France : 1983)|November 25, 2003
[Asplenia and hyposplenism]J Beytout, O Tournilhac, H Laurichesse
Clinical and Experimental Medicine|April 23, 2004
Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advancesV Leblond, O Tournilhac, P Morel
Presse Medicale (Paris, France : 1983)|November 25, 2003
[Antibiotic prophylaxis in splenectomized adults]J Beytout, O Tournilhac, H Laurichesse
Annales De Biologie Clinique|November 28, 2007
[Monoclonal IgM interference with immunoturbidimetric determination of ferritin and transferrin]L Roszyk, B Faye, O Tournilhac, et al.
Bulletin Du Cancer|October 18, 2001
[Allogeneic hematopoietic cell transplantation in solid tumors]J O Bay, B Choufi, O Tournilhac, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2021
Front-line chemo-immunotherapy is not inferior to ibrutinib in CLLM van Gelder, O Tournilhac, D Te Raa, et al.
Bone Marrow Transplantation|July 19, 2016
Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantationA S Zampaolo, J Kanold, O Tournilhac, et al.
Journal De Radiologie|September 3, 2010
[CT imaging features of colitis in neutropenic patients]D Da Ines, V Petitcolin, V Lannareix, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
La Revue Du Praticien|May 25, 1999
[Superficial adenopathy]O Tournilhac, P Travade
Bulletin Du Cancer|June 17, 2000
[Importance of thalidomide in the treatment of cancer]J O Bay, O Tournilhac
Presse Medicale (Paris, France : 1983)|November 25, 2003
[Asplenia and hyposplenism]J Beytout, O Tournilhac, H Laurichesse
Clinical and Experimental Medicine|April 23, 2004
Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advancesV Leblond, O Tournilhac, P Morel
Presse Medicale (Paris, France : 1983)|November 25, 2003
[Antibiotic prophylaxis in splenectomized adults]J Beytout, O Tournilhac, H Laurichesse
Annales De Biologie Clinique|November 28, 2007
[Monoclonal IgM interference with immunoturbidimetric determination of ferritin and transferrin]L Roszyk, B Faye, O Tournilhac, et al.
Bulletin Du Cancer|October 18, 2001
[Allogeneic hematopoietic cell transplantation in solid tumors]J O Bay, B Choufi, O Tournilhac, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2021
Front-line chemo-immunotherapy is not inferior to ibrutinib in CLLM van Gelder, O Tournilhac, D Te Raa, et al.
Bone Marrow Transplantation|July 19, 2016
Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantationA S Zampaolo, J Kanold, O Tournilhac, et al.
Journal De Radiologie|September 3, 2010
[CT imaging features of colitis in neutropenic patients]D Da Ines, V Petitcolin, V Lannareix, et al.
Pageof 6